Interestingly, PCSK9 is a druggable target for cholesterol control and cardiovascular disease found from GWAS and the highest cause of death for NAFLD is heart disease, thereby pointing to a connection between the two diseases [136,137]. Here, PCSK9 is linked to metabolic dysfunction-associated steatotic liver disease.